Back to Results
First PageMeta Content
Immune system / Medicine / Monoclonal antibodies / Crucell / Biologic / Polyclonal antibodies / Cambridge Antibody Technology / Mogamulizumab / Biology / Immunology / Biotechnology


Press Release: Bioceros - through its affiliated company BiocerOX Products and Janssen execute agreement to develop a monoclonal antibody. Utrecht, The Netherlands, January 8, 2014 Dutch Biotech company Bioceros today an
Add to Reading List

Document Date: 2014-01-08 02:14:10


Open Document

File Size: 57,37 KB

Share Result on Facebook

City

Utrecht / /

Company

Bioceros / Kyowa Hakko Kirin / Johnson & Johnson / Janssen Pharmaceuticals Inc. / BiocerOX Products B.V. / /

Country

Netherlands / /

/

Event

Business Partnership / /

IndustryTerm

manufacturing / biotech company offering services / pre-clinical manufacturing / monoclonal antibody / serum-free culture media / cell line development services / /

Organization

Johnson & Johnson London Innovation Centre / /

Person

Bram Bout / Remco Brandt / /

/

Position

Director Tel / CEO / Managing Director / /

Technology

technology of BioWa / antibodies / /

URL

www.bioceros.com / /

SocialTag